Some ligands binding to the activating receptors of NK cells, such as NKG2D and DNAM-1, are expressed in GBM [12], and the ligation of the activating receptors triggers cytotoxicity in NK cells [13]. The gene discussed is CD226; the disease is glioblastoma.